Phibro Animal Health (PAHC) Tops Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Phibro Animal Health Corporation Declares Quarterly Dividend
November 9, 2015 4:47 PM ESTTEANECK, N.J., Nov. 09, 2015 (GLOBE NEWSWIRE) -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock, payable on December 23, 2015, to... More
Phibro Animal Health Corporation Declares Quarterly Dividend
November 9, 2015 4:47 PM ESTTEANECK, N.J., Nov. 09, 2015 (GLOBE NEWSWIRE) -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock, payable on December 23, 2015, to... More
Phibro Animal Health Corporation Reports First Quarter
November 9, 2015 4:45 PM ESTTEANECK, N.J., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its first quarter ended September 30, 2015.
Highlights for the September 2015 quarter (compared to the September 2014 quarter, excluding the prior year milestone payments for licensing of vaccine delivery technology)- Net sales of $187 million, an increase of 3%- Adjusted EBITDA of $27.7 million, an increase of 13%- Adjusted diluted EPS of $0.44 Â compared with $0.36
COMMENTARY Â
I am once again proud of the performance of our team. Despite the economic... More
